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Disclaimer: This guideline is designed primarily as an educational resource for medical geneticists and other healthcare providers
to help them provide quality medical genetic services. Adherence to this guideline does not necessarily assure a successful medical
outcome. This guideline should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and
tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the
geneticistshouldapplyhisorherownprofessionaljudgmenttothespecificclinicalcircumstancespresentedbytheindividualpatient
or specimen. It may be prudent, however, to document in the patient’s record the rationale for any significant deviation from this
guideline.
Geneticistsandgeneticcounselorsareoftenaskedwhatmaybe
appropriate reasons for referral to a genetics service. The Profes-
sional Practice and Guidelines Committee of the American Col-
lege of Medical Genetics has generated lists of the more common
reasons for referral and provide them for use by genetics profes-
sionals and other healthcare providers for guidance. The lists are
divided into pediatric, prenatal, and adult indications.
As genetic health professionals, we are frequently asked un-
der what clinical circumstances a genetic consultation is war-
ranted.Althoughthereisavastarrayofindicationsforreferral,
here are a number of common indications for a genetic office
visit. These lists have been divided into pediatric, preconcep-
tional/prenatal,andadultcategoriesforsimplicity’ssake;find-
ings are paired with consultation objectives. These lists are
clearly not intended to be exhaustive or comprehensive, but
will hopefully serve as a guide for primary care providers who
may have questions about specific clinical circumstances. As
the field of genetics expands and genetic technologies uncover
newgenesandgeneticassociationsonaweeklybasis,theselists
will quickly become outdated. However, for now, these may
help to provide a framework for patient centered specialty re-
ferrals (Tables 1–3).
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Genetic consultation may be helpful under the following circumstances for preconceptional or prenatal patients
Prenatal or preconceptional patient who is or will be:
Finding Reason to consider consultation
Age 35 years or older at the time of delivery (for a singleton pregnancy) Discuss testing options for identifying an age-related chromosome anomaly
Age 33 years or older at the time of delivery (for a twin pregnancy) Discuss testing options for identifying an age-related chromosome anomaly
A close blood relative of her partner (consanguineous union) Review pedigree and assess degree of relatedness; discuss potential
additional fetal risks and testing options before and/or after delivery
Prenatal or preconceptional patient who has:
Finding Reason to consider consultation
An abnormal first or second trimester maternal serum  nuchal translucency
screening test
Discuss risks to pregnancy and testing options
Exposure to a teratogen or potentially teratogenic agent during gestation such
as radiation, high-risk infections (cytomegalovirus, toxoplasmosis,
rubella), drugs, medications, alcohol, etc.
Discuss risks to pregnancy and testing options and rule out significant
fetal  maternal risks
A fetal anomaly or multiple anomalies identified on ultrasound and/or
through echocardiography
Discuss risks to pregnancy and testing options
A personal or family history of pregnancy complications known to be
associated with genetic factors such as acute fatty liver of pregnancy
Rule out significant fetal risks  maternal risks, including a metabolic
disorder
Either member of the couple with:
Finding Reason to consider consultation
A positive carrier screening test for a genetic condition such as cystic fibrosis,
thalassemia, sickle cell anemia, Tay-Sachs, etc.
Discuss additional testing strategies and inheritance
A personal history of stillbirths, previous child with hydrops, recurrent
pregnancy losses (more than two), or a child with sudden infant death
syndrome (SIDS)
Rule out a chromosomal, metabolic, or syndromic diagnosis that may be
associated with an unexplained neonatal death or SIDS
A progressive neurologic condition known to be genetically determined such
as a peripheral neuropathy, unexplained myopathy, progressive ataxia,
early onset dementia, or a familial movement disorder
Discuss a potential diagnosis, the differential diagnosis, inheritance, and
testing options
A statin-induced myopathy Discuss a potential mitochondrial disorder, inheritance and testing options
Either member of the couple with a family or personal history of:
Finding Reason to consider consultation
A birth defect such as a cleft lip  palate, spina bifida, or a congenital heart
defect
Discuss recurrence risks and testing options; discuss folate
supplementation, if appropriate, for subsequent pregnancies
A chromosomal abnormality such as a translocation, marker chromosome, or
chromosomal mosaicism
Discuss risks to the fetus and testing options
Significant hearing or vision loss thought to be genetically determined Discuss risks to the fetus and testing options
Mental retardation or autism Discuss risks to the fetus and testing options
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Genetic consultation may be helpful under the following circumstances for adult patients
Personal history of:
Finding Reason to consider consultation
Abnormal sexual maturation or delayed puberty Rule out an intersex condition, chromosomal abnormality or syndromic
diagnosis (e.g., androgen insensitivity, Klinefelter syndrome)
Recurrent pregnancy losses (RPLs) (more than 2) Rule out a chromosomal rearrangement such as a balanced translocation or
inversion; causes 5%–7% of RPLs
Tall or short stature for genetic background Rule out a skeletal dysplasia, chromosomal or syndromic diagnosis (e.g.,
dyschondrosteosis, Klinefelter syndrome, Marfan syndrome)
One or more birth defects Rule out a chromosomal or syndromic diagnosis (e.g., 22q deletion,
Noonan syndrome); provide genetic counseling and discussion of
preconception folate supplementation, if appropriate
Six or more cafe ´-au-lait macules 1.5 cm in diameter Rule out neurofibromatosis type 1
Statin-induced myopathy Rule out a mitochondrial disorder
Personal or family history of:
Finding Reason to consider consultation
A cancer or cancers known to be associated with specific genes or mutations
such as breast, ovarian, and colorectal in the context of a compelling family
history; young age at onset, bilateral lesions, and familial clustering of
related tumors
Rule out an identifiable mutation in a gene such as BRCA1, FAP, etc.; rule
out a cancer syndrome (e.g., MEN2 or von Hippel-Lindau); discuss
surveillance, treatment, testing options (if presymptomatic), and
inheritance
Cardiovascular problems known to be associated with genetic factors such as
cardiomyopathy, long QT, hyperlipidemia, etc.
Rule out a mutation in a causative or contributory gene; discuss
surveillance, treatment, testing options, and inheritance
Suspected genetic disorder affecting connective tissue Rule out a syndromic diagnosis (e.g., Ehlers-Danlos, Marfan syndrome,
familial joint hypermobility); discuss surveillance, treatment, testing
options, and inheritance
Hematologic condition associated with excessive bleeding or excessive
clotting (as evidenced by recurrent deep vein thromboses or pulmonary
emboli)
Confirm or rule out genetic condition (e.g., one of the hemophilias, von
Willebrand, one of the genetic thrombophilias); discuss treatment,
testing options, and inheritance
Progressive neurologic condition known to be genetically determined such as
a peripheral neuropathy, unexplained myopathy, progressive ataxia, early-
onset dementia, and a familial movement disorder
Confirm or rule out suspected diagnosis, discuss surveillance, treatment,
testing options, and inheritance
Visual loss known to be associated with genetic factors such as retinitis
pigmentosa, early-onset macular degeneration, and cataracts
Rule out a syndromic diagnosis (e.g., Stickler syndrome); discuss testing
options, if applicable, and inheritance
Early-onset hearing loss Rule out a syndromic or nonsyndromic genetic form of hearing loss;
discuss surveillance, testing options, and inheritance
Recognized genetic disorder including a chromosomal or single gene disorder Confirm the diagnosis; discuss prognosis, medical management, and
inheritance
Mental illness such as schizophrenia, depression, bipolar disorder, etc. Discuss diagnosis, inheritance, recurrence risks, and identify syndromes
(e.g., 22q deletion), when possible
Family history of:
Finding Reason to consider consultation
A close relative with a sudden, unexplained death, particularly at a young age Rule out a genetic condition associated with this history, e.g., long QT,
Marfan syndrome, and other cardiac conditions
Indications for Referral
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Genetic consultation may be helpful under the following circumstances for pediatric patients
A neonate with:
Finding Reason to consider consultation
An abnormal newborn screening test Rule out an inborn error of metabolism or other treatable condition;
provide genetic counseling about recurrence risks
Congenital hypotonia or hypertonia Rule out a chromosomal, metabolic, or syndromic diagnosis (e.g., Prader-
Willi syndrome, congenital myotonic dystrophy, hyperekplexia).
Unexplained intrauterine growth retardation Rule out a chromosomal or syndromic diagnosis (e.g., Russell-Silver
syndrome, trisomy 18)
A neonate, infant, or child with:
Finding Reason to consider consultation
A single major, or multiple major and/or minor anomalies Rule out a chromosomal or syndromic diagnosis; provide genetic
counseling for recurrence and possible preventive measures (e.g., folate
supplementation in subsequent pregnancies)
Dysmorphic features that are not familial, especially if accompanied by
developmental delay or mental retardation
Rule out a chromosomal or syndromic diagnosis (numerous conditions)
Failure to thrive Rule out a chromosomal, metabolic, or syndromic diagnosis, or genetic
condition (e.g., IGF1R mutations)
A known metabolic disorder or symptoms of a metabolic disorder such as
intractable seizures, hepatosplenomegaly, acidosis, cyclic vomiting,
persistent hypoglycemia, developmental regression, and unusual body
odor
Diagnose an inborn error of metabolism; discuss treatment and
management; provide genetic counseling
Abnormal brain MRI findings such as leukodystrophy, periventricular
calcifications, unidentified bright objects, or a malformation
Rule out a chromosomal or syndromic diagnosis (e.g., neurofibromatosis,
tuberous sclerosis); provide genetic counseling (e.g., some brain
malformations such as Dandy-Walker malformation may be genetic)
An unusual growth pattern such as overgrowth, short stature, or
hemihypertrophy
Rule out a chromosomal, syndromic, or metabolic diagnosis (e.g., Sotos
syndrome, Beckwith-Wiedemann syndrome, Turner syndrome)
Evidence of a connective tissue disorder such as extreme joint laxity, poor
wound healing, or a marfanoid habitus
Rule out a connective tissue disorder, such as Ehlers-Danlos syndrome,
Marfan syndrome
Congenital eye defects or blindness associated with problems such as
microophthalmia, cataracts, megalocornea, retinitis pigmentosa, or cone-
rod dystrophy
Rule out a syndromic diagnosis; provide genetic counseling for potentially
hereditary ocular conditions
Significant hearing loss or deafness not secondary to recurrent otitis media Rule out a syndromic form of hearing loss (e.g., Waardenburg syndrome)
or identify a genetic form of nonsyndromic hearing loss
Cardiomyopathy not secondary to a viral infection Rule out a mitochondrial disorder or other syndromic or metabolic
diagnosis (e.g., carnitine deficiencies, Noonan syndrome, several forms
of muscular dystrophy); provide genetic counseling for potentially
hereditary forms of cardiomyopathy
Six or more cafe ´-au-lait macules 0.5 cm in diameter Rule out neurofibromatosis type 1
Unusual skin findings such as multiple types of lesions, multiple lipomas,
numerous hypo- or hyperpigmented lesions, and albinism
Rule out a chromosomal or syndromic diagnosis (e.g., chromosomal
mosaicism, tuberous sclerosis, Cowden syndrome)
Born to a parent with a known chromosomal abnormality or rearrangement
(balanced or unbalanced), especially if there are dysmorphic features and/
or cognitive impairment
Rule out a chromosomal abnormality
Bilateral or multifocal malignancies such as retinoblastoma or Wilms tumor Rule out a cancer syndrome or other chromosomal or syndromic diagnosis
(e.g., aniridia-Wilms tumor caused by 11p13 deletion); provide genetic
counseling for recurrence
Problems with clotting including disorders such as hemophilia and
thrombophilia
Rule out an inherited clotting disorder as well as some syndromes (e.g.,
Noonan syndrome)
A recognized or suspected genetic syndrome including a chromosomal or
single gene disorder
Confirm the diagnosis and discuss the prognosis, medical management,
inheritance, and recurrence risks
A significant family history of medical or psychiatric conditions that puts the
patient at risk of developing the same or similar disorder
Discuss diagnosis, inheritance, and possible testing options
(continued)
Pletcher et al.
388 Genetics IN MedicineTable 3.
Continued
A child with:
Finding Reason to consider consultation
Unexplained mental retardation or global developmental disorder Rule out a chromosomal, syndromic or metabolic diagnosis (e.g., fragile X,
sex chromosome anomaly, some forms of mucopolysaccharidoses)
Autism or pervasive developmental disorder Rule out a chromosomal or syndromic diagnosis (e.g., fragile X, Angelman
syndrome, Rett syndrome)
Unusual behaviors, especially when associated with minor malformations
and developmental delay or mental retardation
Rule out a chromosomal or syndromic diagnosis (e.g., Smith-Magenis
syndrome, Lesch-Nyhan syndrome)
An immunodeficiency or significant immune problem Rule out a syndromic diagnosis (e.g., 22q deletion) or genetic form of
immunodeficiency (e.g., severe combined immunodeficiency syndrome)
Progressive muscle weakness that might be associated with a genetic disorder
such as a form of muscular dystrophy, spinal muscular atrophy, or
myotonic dystrophy
Confirm suspected diagnosis and provide genetic counseling
Other neurologic condition that might be associated with a genetic
predisposition such as a peripheral neuropathy, unexplained myopathy,
progressive ataxia, or any progressive neurologic disorder without a clear,
nongenetic cause
Rule out a genetic diagnosis (e.g., spinocerebellar ataxia, Huntington
disease), provide genetic counseling
Indications for Referral
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